Pharmalot.. Pharmalittle.. Good Morning.. We’re catching up on Valeant, Walgreen and..
Good morning, folks. A happy, shiny sun is hovering over the Pharmalot campus where, after a brief road trip, we have resumed our usual ritual of brewing needed cups of stimulation and foraging for interesting items. However, we are also kvelling since our shortest of short people celebrates a birthday. We will tend to that later, though, since a long to-do list awaits. As always, we hope you have a smashing day and, of course, do keep in touch…
The New England Journal of Medicine has endorsed Robert Califf as the next FDA commissioner amid chatter that he has a pro-industry tilt; The widely used class of cholesterol-lowering drugs known as statins may undermine the effectiveness of flu shots; Valeant Pharmaceutical relies on some pushy, “back door” tactics to get prescriptions filled; and two US senators urged the US Federal Trade Commission to scrutinize the Walgreens Boots Alliance $9.4 billion bid for Rite Aid.